AbbVie (ABBV) FCF Margin (2012 - 2026)

AbbVie has disclosed FCF Margin across 15 years of filings, most recently posting 23.76% for Q1 2026.

• In Q1 2026, FCF Margin rose 1326.0% year-over-year to 23.76%; the TTM figure through Mar 2026 stood at 31.81% (up 499.0% YoY), while the FY2025 annual figure was 29.13%, down 252.0% from the prior year.
• FCF Margin fell to 23.76% in Q1 2026, from 29.42% in the prior quarter.
• Over the last five years, FCF Margin for ABBV reached as high as 52.81% in Q3 2023 and fell as low as 10.49% in Q1 2025.
• The 5-year median for FCF Margin is 33.34% (2022), against an average of 34.79%.
• Annual changes were most pronounced in 2024 — FCF Margin slumped 3025 bps — and 2025, when it surged 1763 bps.
• A 5-year view of FCF Margin shows it stood at 47.72% in 2022, then sank by 33 bps to 31.8% in 2023, then jumped by 41 bps to 44.74% in 2024, then slumped by 34 bps to 29.42% in 2025, then dropped by 19 bps to 23.76% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 23.76%, 29.42%, and 42.11% for Q1 2026, Q4 2025, and Q3 2025 respectively.